MSLN and neoplasm: (63) found that shRNA-mediated A2aR interference can also improve the anti-mSLN-CAR T cell anti-tumor effect in vivo and in vitro, and proved that shRNA-mediated gene expression modification may be an excellent strategy for improving CAR T cell function in immunosuppressive TME.